Skip to main content

Table 1 Anthropometric parameters and clinical characteristics of participants

From: Relationship between circulating miR-132 and non-alcoholic fatty liver disease in a Chinese population

 Non-diabetes groupP valuesDiabetic groupP value
Control (N = 67)NAFLD (N = 73)Control (N = 68)NAFLD (N = 66)
Age (years)57.87 ± 6.8457.28 ± 6.660.60557.74 ± 6.8357.21 ± 6.460.647
Male/female (n)47/2050/230.83246/2246/200.798
BMI (kg/m2)24.39 ± 1.9624.89 ± 2.140.15657.74 ± 6.8357.21 ± 6.460.647
FPG (mmol/L)5.56 ± 0.475.82 ± 0.500.0027.22 ± 1.297.15 ± 1.310.757
2 h PG (mmol/L)7.04 ± 1.618.03 ± 1.64<  0.00112.95 ± 3.6912.85 ± 3.310.87
HbA1C (%)5.58 ± 0.315.59 ± 0.400.7786.17 ± 1.126.45 ± 0.830.108
ALT (U/L)20.58 ± 5.4033.52 ± 13.84<  0.00116.59 ± 6.9623.14 ± 10.96< 0.001
AST (U/L)22.81 ± 5.1727.51 ± 9.03<  0.00121.09 ± 5.2523.03 ± 5.540.039
GGT (U/L)22.85 ± 8.0047.56 ± 28.84<  0.00122.76 ± 9.0435.98 ± 23.31< 0.001
TG (mmol/L)1.25 ± 0.602.02 ± 1.11<  0.0011.38 ± 0.771.98 ± 1.13< 0.001
TC (mmol/L)5.19 ± 0.935.35 ± 1.020.3504.97 ± 0.905.34 ± 0.930.021
LDL-C (mmol/L)3.24 ± 0.773.36 ± 0.840.3573.03 ± 0.753.36 ± 0.750.012
HDL-C(mmol/L)1.36 ± 0.291.22 ± 0.240.0021.28 ± 0.261.24 ± 0.290.349
APOA (mmol/L)1.39 ± 0.281.4 ± 0.260.7831.45 ± 0.301.38 ± 0.330.179
APOB (mmol/L)0.89 ± 0.170.93 ± 0.170.0930.87 ± 0.150.94 ± 0.150.068
APOE (mmol/L)4.26 ± 1.565.07 ± 2.010.0094.34 ± 1.774.85 ± 1.660.090
FFA (umol/L)503.16 ± 185.25528.46 ± 152.500.382647.09 ± 249.14640.25 ± 244.140.874
  1. Data are shown as mean ± standard deviation. P value indicates the comparison of non-alcoholic fatty liver disease (NAFLD) and control subjects
  2. Abbreviations: 2hPG 2-h plasma glucose, FPG Fasting plasma glucose, ALT Aspartate aminotransferase, AST Alanine aminotransferase, ALT Alanine aminotransferase, TG Triglyceride, TC Total cholesterol, APOE Apolipoprotein E, APOA Apolipoprotein A, APOA Apolipoprotein A, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, FFA Free fatty acids